Table 2.
Laboratory findings at admission.
| Missing data | All (n = 110) | Uncomplicated (n = 73) | ICU (n = 26) | Death (n = 11) | ||
|---|---|---|---|---|---|---|
| Parameter | n | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | p -value* |
| Hemoglobin (g/dL) | 3 | 13.2 (12.2–14.5) | 13.3 (12.2–14.7) | 13.8 (12.6–14.7) | 12.2 (11.2–13.0) | p = 0.069 |
| Red blood cell count (x012/L) | 3 | 4.6 (4.1–5–0) | 4.6 (4.1–5.1) | 4.7 (4.4–5.1) | 4.2 (3.5–4.3) | p = 0.019 |
| Platelet count (x109/L) | 3 | 182 (146–235) | 179 (146–239) | 182 (137–224) | 198 (161–245) | p = 0.777 |
| Leukocyte count (x109/L) | 3 | 6.0 (4.2–7.5) | 5.4 (3.8–6.8) | 6.8 (5.4–9.0) | 6.5 (5.2–8.8) | p = 0.029 |
| Lymphocyte count (x109/L) | 10 | 0.8 (0.6–1.2) | 0.9 (0.6–1.3) | 0.8 (0.7–1.1) | 0.7 (0.5–0.8) | p = 0.157 |
| Neutrophil count (x109/L) | 10 | 4.5 (3.1–6.0) | 3.9 (2.9–5.5) | 5.2 (3.6–8.0) | 5.0 (3.8–7.1) | p = 0.038 |
| Monocyte count (x109/L) | 10 | 0.3 (0.2–0.5) | 0.3 (0.2–0.5) | 0.3 (0.2–0.4) | 0.4 (0.3–0.6) | p = 0.138 |
| Eosinophil count (x109/L) | 10 | 0.01 (0.00–0.03) | 0.01 (0.00–0.04) | 0.01 (0.00–0.01) | 0.01 (0.00–0.03) | p = 0.443 |
| Basophil count (x109/L) | 10 | 0.02 (0.01–0.04) | 0.02 (0.01–0.04) | 0.02 (0.02–0.03) | 0.02 (0.01–0.03) | p = 0.427 |
| C-reactive protein (mg/L) | 3 | 59.5 (32.8–88.8) | 55.0 (25.7–77.4) | 83.8 (59.5–112.6) | 57.4 (34.1–140.0) | p = 0.017 |
| D-dimer (mg/L) | 21 | 0.7 (0.5–1.1) | 0.7 (0.5–1.1) | 0.6 (0.4–1.0) | 1.4 (0.6–3.6) | p = 0.265 |
| Prothrombin time (%) | 7 | 100.0 (89.7–109.6) | 99.9 (88.6–111.4) | 101.4 (91.4–110.4) | 96.9 (91.6–103.1) | p = 0.653 |
| International normalized ratio | 8 | 1.0 (1.0–1.1) | 1.0 (1.0–1.1) | 1.0 (1.0–1.1) | 1.0 (1.0–1.1) | p = 0.752 |
| Activated partial thromboplastin time (s) | 14 | 32.6 (29.1–36.9) | 32.7 (29.1–37.2) | 32.4 (28.8–33.8) | 31.0 (30.2–37.9) | p = 0.799 |
*
p < 0.05. Metric variables were compared using Kruskal Wallis test; ICU, intensive care unit; IQR, interquartile range. Bold values highlight statistically significant data.